Molecules (Mar 2022)

Inhibition of Filamentous Thermosensitive Mutant-Z Protein in <i>Bacillus subtilis</i> by Cyanobacterial Bioactive Compounds

  • Manisha Gurnani,
  • Prangya Rath,
  • Abhishek Chauhan,
  • Anuj Ranjan,
  • Arabinda Ghosh,
  • Rup Lal,
  • Nobendu Mukerjee,
  • Nada H. Aljarba,
  • Saad Alkahtani,
  • Vishnu D. Rajput,
  • Svetlana Sushkova,
  • Evgenya V. Prazdnova,
  • Tatiana Minkina,
  • Tanu Jindal

DOI
https://doi.org/10.3390/molecules27061907
Journal volume & issue
Vol. 27, no. 6
p. 1907

Abstract

Read online

Antibiotic resistance is one of the major growing concerns for public health. Conventional antibiotics act on a few predefined targets and, with time, several bacteria have developed resistance against a large number of antibiotics. The WHO has suggested that antibiotic resistance is at a crisis stage and identification of new antibiotics and targets could be the only approach to bridge the gap. Filamentous Temperature Sensitive-Mutant Z (Fts-Z) is one of the promising and less explored antibiotic targets. It is a highly conserved protein and plays a key role in bacterial cell division by introducing a cytokinetic Z-ring formation. In the present article, the potential of over 165 cyanobacterial compounds with reported antibiotic activity against the catalytic core domain in the Fts-Z protein of the Bacillus subtilis was studied. The identified cyanobacterial compounds were screened using the GLIDE module of Maestro v-2019-2 followed by 100-ns molecular dynamics (MD) simulation. Ranking of the potential compound was performed using dock score and MMGBSA based free energy. The study reported that the docking score of aphanorphine (−6.010 Kcalmol−1) and alpha-dimorphecolic acid (ADMA) (−6.574 Kcalmol−1) showed significant role with respect to the reported potential inhibitor PC190723 (−4.135 Kcalmol−1). A 100 ns MD simulation infers that Fts-Z ADMA complex has a stable conformation throughout the progress of the simulation. Both the compounds, i.e., ADMA and Aphanorphine, were further considered for In-vitro validation by performing anti-bacterial studies against B. subtilis by agar well diffusion method. The results obtained through In-vitro studies confirm that ADMA, a small molecule of cyanobacterial origin, is a potential compound with an antibacterial activity that may act by inhibiting the novel target Fts-Z and could be a great drug candidate for antibiotic development.

Keywords